Yonghe Medical Group Co., Ltd.

SEHK:2279 Stock Report

Market Cap: HK$430.3m

Yonghe Medical Group Management

Management criteria checks 3/4

Yonghe Medical Group's CEO is Yu Zhang, appointed in Jul 2010, has a tenure of 14.42 years. total yearly compensation is CN¥1.72M, comprised of 96% salary and 4% bonuses, including company stock and options. directly owns 36.29% of the company’s shares, worth HK$156.12M. The average tenure of the management team and the board of directors is 2.6 years and 3.5 years respectively.

Key information

Yu Zhang

Chief executive officer

CN¥1.7m

Total compensation

CEO salary percentage96.0%
CEO tenure14.4yrs
CEO ownership36.3%
Management average tenure2.6yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Bounce 36% But Its Business Still Trails The Industry

Dec 12
Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Bounce 36% But Its Business Still Trails The Industry

Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Leap 60% Yet They're Still Not Telling The Full Story

Sep 30
Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Leap 60% Yet They're Still Not Telling The Full Story

Is Yonghe Medical Group (HKG:2279) Using Debt Sensibly?

May 24
Is Yonghe Medical Group (HKG:2279) Using Debt Sensibly?

It's Down 34% But Yonghe Medical Group Co., Ltd. (HKG:2279) Could Be Riskier Than It Looks

Mar 31
It's Down 34% But Yonghe Medical Group Co., Ltd. (HKG:2279) Could Be Riskier Than It Looks

Are Yonghe Medical Group Co., Ltd. (HKG:2279) Investors Paying Above The Intrinsic Value?

Oct 19
Are Yonghe Medical Group Co., Ltd. (HKG:2279) Investors Paying Above The Intrinsic Value?

The Consensus EPS Estimates For Yonghe Medical Group Co., Ltd. (HKG:2279) Just Fell Dramatically

Sep 08
The Consensus EPS Estimates For Yonghe Medical Group Co., Ltd. (HKG:2279) Just Fell Dramatically

Is Yonghe Medical Group Co., Ltd. (HKG:2279) Expensive For A Reason? A Look At Its Intrinsic Value

Aug 19
Is Yonghe Medical Group Co., Ltd. (HKG:2279) Expensive For A Reason? A Look At Its Intrinsic Value

Yonghe Medical Group's (HKG:2279) Soft Earnings Don't Show The Whole Picture

Mar 31
Yonghe Medical Group's (HKG:2279) Soft Earnings Don't Show The Whole Picture

CEO Compensation Analysis

How has Yu Zhang's remuneration changed compared to Yonghe Medical Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CN¥453m

Mar 31 2024n/an/a

-CN¥496m

Dec 31 2023CN¥2mCN¥2m

-CN¥538m

Sep 30 2023n/an/a

-CN¥430m

Jun 30 2023n/an/a

-CN¥322m

Mar 31 2023n/an/a

-CN¥203m

Dec 31 2022CN¥1mCN¥1m

-CN¥84m

Sep 30 2022n/an/a

CN¥6m

Jun 30 2022n/an/a

CN¥95m

Mar 31 2022n/an/a

CN¥107m

Dec 31 2021CN¥1mCN¥1m

CN¥118m

Sep 30 2021n/an/a

CN¥121m

Jun 30 2021n/an/a

CN¥125m

Mar 31 2021n/an/a

CN¥136m

Dec 31 2020CN¥5mCN¥1m

CN¥147m

Dec 31 2019CN¥1mCN¥900k

CN¥36m

Dec 31 2018CN¥580kCN¥455k

CN¥54m

Compensation vs Market: Yu's total compensation ($USD235.12K) is about average for companies of similar size in the Hong Kong market ($USD231.18K).

Compensation vs Earnings: Yu's compensation has increased whilst the company is unprofitable.

CEO

Yu Zhang (38 yo)

14.4yrs

Tenure

CN¥1,716,000

Compensation

Mr. Yu Zhang is Chairman of the Board, Executive Director & CEO of Yonghe Medical Group Co., Ltd. He joined the Yonghe Medical Group Co., Ltd. in July 2010.He is Founder of onghe Medical Group Co., Ltd. M...

Leadership Team

NamePositionTenureCompensationOwnership
Yu Zhang
Chairman of the Board & CEO14.4yrsCN¥1.72m36.29%
HK$ 156.1m
Zhimei Han
Executive Director7.8yrsCN¥1.10m0.072%
HK$ 311.8k
Hui Zhang
Senior VP of the Integrated Management Center & Executive Director3.5yrsCN¥1.10m4.85%
HK$ 20.9m
Yang Xu
Chief Executive Officer of Innovation Business Unit1.6yrsno datano data
Jian Ren
Chief Growth Officer2.6yrsno datano data
Yang SU
Chief Operating Officer of Yonghe Business Line1.6yrsno datano data
Wai Kam Ng
Joint Company Secretaryless than a yearno datano data

2.6yrs

Average Tenure

39.5yo

Average Age

Experienced Management: 2279's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yu Zhang
Chairman of the Board & CEO4.3yrsCN¥1.72m36.29%
HK$ 156.1m
Zhimei Han
Executive Director2.5yrsCN¥1.10m0.072%
HK$ 311.8k
Hui Zhang
Senior VP of the Integrated Management Center & Executive Director4.3yrsCN¥1.10m4.85%
HK$ 20.9m
Peng Kuan Chan
Independent Non-Executive Director3.5yrsCN¥181.00kno data
Jihong Liang
Independent Non-Executive Director2.5yrsCN¥180.00kno data
Jiaqi Geng
Non-Executive Director4.3yrsno data0.13%
HK$ 566.5k
Xiaopei Li
Independent Non-Executive Director3.5yrsCN¥180.00kno data

3.5yrs

Average Tenure

46yo

Average Age

Experienced Board: 2279's board of directors are considered experienced (3.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 00:27
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yonghe Medical Group Co., Ltd. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yichi ZhangChina International Capital Corporation Limited
Junhao ZhangGuosen Securities Co., Ltd.
Liting WangHaitong International Research Limited